Skip to the comparison

Data profile · Updated 19 Nov 2026

FlatRx: GLP‑1 pricing and terms

4 reviews

Trustpilot, too few to average · read 19 Nov 2026

What you pay

$99 medication and care

$99/mo

no membership fee, and we checked

✓ Verified 19 Nov 2026

First year

$1,188–$1,416 month-to-month plans, cheapest to most expensive product

Cancellation

Portal message or email

The price receipt

What makes up the total

Medication / month
$99
Membership / month
$0
Due upfront
$99

Billed monthly, no commitment stated

Price verified ✓ Price checked

9.2/10 VerifiedDose score How we score this →

What FlatRx charges, read from its own pages on 19 Nov 2026.

  • Every dose priced
  • No membership fee

What each plan costs

  • SemaglutideCompounded · 3-month plan, $267 up front $89
  • SemaglutideCompounded $99
  • TirzepatideCompounded · 3-month plan, $327 up front $109
  • TirzepatideCompounded $118

Compounded medications are not FDA-approved: "Compounded drugs are not approved by FDA" (FDA, page current as of 1 Apr 2026, read 14 Oct 2026 (opens in a new tab)).

✓ Prices checked 19 Nov 2026

How much does FlatRx cost?

Read from the provider's own pages

At its lowest dated price, FlatRx costs $99 a month, with no membership fee on top, checked 19 Nov 2026.

Every plan FlatRx publishes, with the price we verified and the date.
Plan Form Price
Semaglutide, All doses, monthly Injection Compounded $99 Price verified ✓ Price checked
Semaglutide, All doses, 3-month plan Injection Compounded $89 3-month plan, $267 up front Price verified ✓ Price checked
Tirzepatide, All doses, monthly Injection Compounded $118 Price verified ✓ Price checked
Tirzepatide, All doses, 3-month plan Injection Compounded $109 3-month plan, $327 up front Price verified ✓ Price checked

Provider review, medication if prescribed, shipping and provider messaging

How much is compounded semaglutide at FlatRx?

Compounded semaglutide at FlatRx starts at $99 a month, with no membership fee on top, checked 19 Nov 2026.

How much is compounded tirzepatide at FlatRx?

Compounded tirzepatide at FlatRx starts at $118 a month, with no membership fee on top, checked 19 Nov 2026.

Where FlatRx sits in our price rankings: 1st of 38 in Cheapest GLP-1 telehealth · 1st of 34 in Best tirzepatide telehealth by price · 1st of 13 in Cheapest GLP-1 without membership. Each ranking groups providers by how they bill and whether we know their fee, then orders each group by what a year costs at the verified price.

What Tirzepatide costs across every channel we track is in our Tirzepatide price guide. What Semaglutide costs across every channel we track is in our Semaglutide price guide.

What stands out

  • Dose pricing Every dose priced
  • Insurance Insurance filing not recorded
  • Regulatory record Nothing found in our search
  • Legal entity Legal entity published
  • Cancellation Portal message or email

FlatRx reviews

Third-party aggregate, quoted not endorsed

4reviews on Trustpilot, read 19 Nov 2026

Too small a base to average: below about a hundred reviews a handful of entries moves the score a full point, so we report how many people have written and leave the average unpublished.

See the profile on Trustpilot (opens in a new tab)

Is FlatRx legit? Its company and regulatory record

Primary sources only

We don't certify companies; this is the record we hold for FlatRx. Legal entity on file: Leanio Health LLC. Registered: New York LLC, first filed 12 Mar 2026. Prescribing clinicians on file: Wasef Health, PC, a medical group separate from FlatRx, by FlatRx's own account. Pharmacies on file: US-licensed 503A compounding pharmacies, unnamed on the pages we read. Street address on file: none on its site; FlatRx confirmed this by email on 19 Nov 2026. Each is linked to its source in the Terms panel on this page. We hold no regulatory flags for it; we last searched on 19 Nov 2026.

We found no matching action in the sources we searched on 19 Nov 2026: FDA warning letters, CourtListener court records and New York's company registry, plus web searches limited to ftc.gov and ag.ny.gov. We could not search medical boards: FlatRx names no prescriber.

What has changed

Append-only

First membership fee on record: none

FlatRx not published → $0

Observation and source

Recorded here on 20 Nov 2026. This entry predates our observation log, so the day the provider's page changed is not on file.

First price on record

FlatRx $109

Observation and source

Seen on the provider's own page on 19 Nov 2026, recorded here on 20 Nov 2026.

Tirzepatide All doses, 3-month plan — read from the provider's own page on 19 Nov 2026.

The page this was read from (opens in a new tab)

First price on record

FlatRx $118

Observation and source

Seen on the provider's own page on 19 Nov 2026, recorded here on 20 Nov 2026.

Tirzepatide All doses, monthly — read from the provider's own page on 19 Nov 2026.

The page this was read from (opens in a new tab)

First price on record

FlatRx $89

Observation and source

Seen on the provider's own page on 19 Nov 2026, recorded here on 20 Nov 2026.

Semaglutide All doses, 3-month plan — read from the provider's own page on 19 Nov 2026.

The page this was read from (opens in a new tab)

First price on record

FlatRx $99

Observation and source

Seen on the provider's own page on 19 Nov 2026, recorded here on 20 Nov 2026.

Semaglutide All doses, monthly — read from the provider's own page on 19 Nov 2026.

The page this was read from (opens in a new tab)

Go to the provider

Sources

How this site works

How we rate providers

Ratings weigh verified price, total first-year cost, state availability, speed to prescription, cancellation terms and regulatory record. Full scoring rubric.

No clinical review

We are not clinicians and this page carries no clinical review. Drug and regulatory facts are cited directly from FDA, CMS and court records, never a provider's marketing claims.

How we make money

When you sign up with a provider through our links, we may earn a referral fee. Fees never influence a rating, a price, or a position in a table. Full advertiser disclosure.